DDR2 and melanoma: To address the contribution of DDR in MMDR, a siRNA approach was then used to target DDR1, DDR2, or both in melanoma cells cultured on MAF‐ or FRC‐derived ECMs, in the presence of BRAFi alone or in combination with MEKi.